Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity [superscript 86]Y- or [superscipt 177]Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates
Purpose: GPA33 is a colorectal cancer (CRC) antigen with unique retention properties after huA33-mediated tumor targeting. We tested a pretargeted radioimmunotherapy (PRIT) approach for CRC using a tetravalent bispecific antibody with dual specificity for GPA33 tumor antigen and DOTA-Bn–(radiolantha...
Main Authors: | Xu, Hong, Guo, Hong-fen, Lee, Sang-gyu, Punzalan, Blesida, Chalasani, Sandhya, Jungbluth, Achim, O’Donoghue, Joseph, Cheal, Sarah M., Fung, Edward K., Zanzonico, Pat B., Carrasquillo, Jorge A., Smith-Jones, Peter M., Cheung, Nai-Kong V., Larson, Steven M., Wittrup, Karl Dane |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Language: | English |
Published: |
Springer Berlin Heidelberg
2016
|
Online Access: | http://hdl.handle.net/1721.1/104432 |
Similar Items
-
Improved mehtods and reagents for pretargeted radioimmunotherapy of cancer
by: Zajic, Stefan C
Published: (2007) -
Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers
by: Green, Damian J., et al.
Published: (2020) -
Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and 90 Y-DOTA
by: Orozco, Johnnie J, et al.
Published: (2021) -
Effect of Small-Molecule-Binding Affinity on Tumor Uptake In Vivo: A Systematic Study Using a Pretargeted Bispecific Antibody
by: Rhoden, John J., et al.
Published: (2014) -
Dota2 pre-game prediction
by: Wu, Hao
Published: (2020)